XFRA DIVERSE: WIEDERAUFNAHME/RESUMPTION

Realtime	Geld	Brief	Zeit
	67,00	70,00	26.07.

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.

THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:

INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
CANADIAN PAC KA.CITY LTD. X88 CA13646K1084
LINCOLN GOLD MINING INC. ZMG CA53359R2054
LION ROCK RES.INC. KGB CA5362502026
MEGAWATT LITH.BATT.METALS WR2 CA58518J2002
PERMEX PETROLEUM 75P CA71422P3034
RIGHT SEASON INV.CORP. T50 CA76658Q2062
SILVER NORTH RESOURCES I90 CA8280611010
WEST MINING CORP. O.N. 1HL0 CA9546062089
CRH PLC EO-,32 CRG IE0001827041
COLLPLANT BIOTECH. IS-,01 CPT IL0004960188
TOP SHIPS DL-,01 UER0 MHY8897Y2307
ATL. BRV. HLDG. C DL-,001 E450 US0477263026
CURIS INC. DL -,01 CUS0 US2312693094
DIANTHUS THERAPEUTICS 87E US2528281080
ELICIO THERAP. DL-,01 9HA US28657F1030
GYRE THERAPEUTICS L9S US4037831033
HARPOON THERAPEUTICS 5HTA US41358P2056
HOWARD HUGHES HOL.INC NEW HHE0 US44267T1025
MARKER THERAPEUTICS INC. GX1 US57055L2060
SINCLAIR INC. A HQ7 US8292421067
SPI.GL.INC. CL.A DL-,0001 EL9 US8485603067
SYNCHRONOSS NEW DL-,0001 H6K0 US87157B4005
VACASA INC. CL.A NEW O.N. W5Q0 US91854V2060
AB/FROM ONWARDS 05.01.2024 14:15 CET

	Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Xetra-Orderbuch


	Fonds	Kurs	%


	Devisen	Kurs	%


	Rohstoffe	Kurs	%


	Themen	Kurs	%



Erweiterte Suche

Zeit	Aktuelle Nachrichten
11.07.	Atlanta Braves Holdings, Inc. - 8-K, Current Report
13.06.	Atlanta Braves Holdings re-elects director, approves proposals
17.05.	Tidal Wave Auto Spa Announces Official Partnership With the Atlanta Braves	Tidal Wave's First Partnership with a Major League Sports Team to Include On-site Activations, Exclusive Giveaways, Community Events, and MoreTHOMASTON, GA / ACCESSWIRE / May 17, 2024 / Tidal Wave Auto... ► Artikel lesen
08.05.	Atlanta Braves Holdings, Inc. - 8-K, Current Report
08.05.	Atlanta Braves Holdings, Inc. - 10-Q, Quarterly Report

Zeit	Aktuelle Nachrichten
Di	What's in Store for Canadian Pacific KC (CP) in Q2 Earnings?
11.07.	Here's Why Investors Should Retain Canadian Pacific KC (CP)
09.07.	Canadian Pacific Kansas City Ltd: Canadian Pacific Kansas to release Q2 results July 30
09.07.	CP RailKC to report second-quarter 2024 earnings results on July 30, 2024
01.07.	Teamsters Canada Rail Conference members reauthorize strikes against CN, CPKC

Zeit	Aktuelle Nachrichten
06.06.	CollPlant Biotechnologies Ltd - 6-K, Report of foreign issuer
30.05.	CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q1 2024 Earnings Call Transcript
29.05.	CollPlant Biotechnologies Ltd - S-8, Securities to be offered to employees in employee benefit plans
29.05.	Earnings call: CollPlant reports Q1 2024 results and corporate updates
29.05.	CollPlant Biotechnologies Non-GAAP EPS of -$0.35, revenue of $0.1M misses by $0.53M

Zeit	Aktuelle Nachrichten
Fr	Looking Into CRH's Recent Short Interest
Do	CRH plc: CRH Announces Date for Q2 2024 Results Conference Call	CRH plc (NYSE: CRH), the leading provider of building materials solutions, will publish its Q2 2024 financial results on Thursday, August 8, 2024 at 2:00 a.m. (New York) 7:00 a.m. (Dublin) followed... ► Artikel lesen
Di	CRH expands footprint in Colorado with acquisition of Ary Corporation
Mo	CRH Acquires Colorado-Based Ary Corporation	CRH today announced the acquisition of Ary Corporation, a leading provider of building materials solutions headquartered in Canon City, Colorado. This acquisition expands CRH's Americas Materials... ► Artikel lesen
Mo	Here's How Much You Would Have Made Owning CRH Stock In The Last 5 Years

Zeit	Aktuelle Nachrichten
08.07.	Curis, Inc.: Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	LEXINGTON, Mass., July 8, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4... ► Artikel lesen
08.07.	Will Curis' TakeAim Trials Hit The Mark?	WASHINGTON (dpa-AFX) - Curis Inc. (CRIS), a biotechnology company developing novel therapies for slowing or preventing the progression of cancer and prolonging life, has several important clinical... ► Artikel lesen
24.06.	Carasent ASA: Carasent group signs contract to supply Ad Curis to Frelsesarmeen
14.06.	CURIS INC - S-8, Securities to be offered to employees in employee benefit plans
23.05.	CURIS INC - 8-K, Current Report

Zeit	Aktuelle Nachrichten
Fr	Baird starts Dianthus at outperform, cites lead drug DNTH103
08.07.	Dianthus (DNTH) Gains 18% in the Past Month: Here's Why
01.07.	Dianthus reveals preclinical data for its Phase II neuromuscular candidate
28.06.	Dianthus Therapeutics, Inc.: Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)
12.06.	Dianthus wins FDA nod to start mid-stage trial for lead asset

Zeit	Aktuelle Nachrichten
28.06.	Why Is Cancer Vaccine Developer Elicio Therapeutics Stock Trading Lower On Friday?
28.06.	Pre-market Movers: Cosmos Health, Carisma Therapeutics, Elicio Therapeutics, Nexalin Technology, Accolade	WASHINGTON COUNTY (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.45 A.M. ET).In the Green Cosmos Health Inc. (COSM) is up over 66%... ► Artikel lesen
28.06.	Elicio Therapeutics Inc.: Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public Offering
28.06.	Why Is Elicio Therapeutics (ELTX) Stock Down 36% Today?
27.06.	Elicio Therapeutics announces proposed public offering

Zeit	Aktuelle Nachrichten
05.07.	GYRE THERAPEUTICS, INC. - 8-K, Current Report
02.07.	Gyre Therapeutics Gets China's Approval For Tablets For Thrombocytopenia Treatment
02.07.	Gyre Therapeutics, Inc.: Gyre Therapeutics Announces China's NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia	SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics ("Gyre") (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on a... ► Artikel lesen
18.06.	Gyre Therapeutics, Inc.: Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
17.06.	GYRE THERAPEUTICS, INC. - 8-K, Current Report

HOWARD HUGHES HOLDINGS INC

XFRA DIVERSE: WIEDERAUFNAHME/RESUMPTION